Literature DB >> 15065474

Objective assessment of psychomotor retardation in primary care patients with depression.

Grant L Iverson1.   

Abstract

The relationship between activity level and depression in primary care outpatients was examined. Forty-eight patients with depression and 25 general medical controls wore a heart and activity level monitor for 24 h. Minute-averaged horizontal movement was collected. Patients with depression were sorted into two equal groups based on a median split of their Beck Depression Inventory-II scores. ANOVAs revealed significant main effects for average movement over the 24-h interval, average movement between 12 and 6 P.M., and a measure of "high activity" level. Patients with more severe depression had lower activity levels than the other two patient groups. The nondepressed and less severely depressed groups were combined and compared to the more severely depressed group using a standard discriminant function analysis. The overall correct classification rate was 74.0%, with 86% of the combined group and 50% of the more severely depressed group correctly classified. Patients with low activity levels were 6.0 times more likely to fall in the severely depressed group than patients with more normal activity levels.

Entities:  

Mesh:

Year:  2004        PMID: 15065474     DOI: 10.1023/b:jobm.0000013642.43978.f9

Source DB:  PubMed          Journal:  J Behav Med        ISSN: 0160-7715


  13 in total

1.  Psychomotor activity, sleep, and biogenic amine metabolites in depression.

Authors:  B L Weiss; D J Kupfer; F G Foster; J Delgado
Journal:  Biol Psychiatry       Date:  1974-08       Impact factor: 13.382

2.  Psychomotor activity in affective states.

Authors:  D J Kupfer; B L Weiss; G Foster; T P Detre; R McPartland
Journal:  Arch Gen Psychiatry       Date:  1974-06

Review 3.  Actigraphy and motion analysis: new tools for psychiatry.

Authors:  M H Teicher
Journal:  Harv Rev Psychiatry       Date:  1995 May-Jun       Impact factor: 3.732

4.  Psychomotor retardation found in depressed outpatient women.

Authors:  C S Futterman; W W Tryon
Journal:  J Behav Ther Exp Psychiatry       Date:  1994-03

5.  Motor activity and affective illness. The relationship of amplitude and temporal distribution to changes in affective state.

Authors:  E A Wolff; F W Putnam; R M Post
Journal:  Arch Gen Psychiatry       Date:  1985-03

6.  Effects of lithium carbonate on motor activity in mania and depression.

Authors:  G R Heninger; L Kirstein
Journal:  J Nerv Ment Dis       Date:  1977-03       Impact factor: 2.254

7.  Quantitative assessment of psychomotor activity in patients with neuroleptic-induced akathisia.

Authors:  G Gardos; M H Teicher; J F Lipinski; J D Matthews; L Morrison; C Conley; J O Cole
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1992-01       Impact factor: 5.067

8.  Motor activity and severity of depression in hospitalized prepubertal children.

Authors:  E T Aronen; M H Teicher; D Geenens; S Curtin; C A Glod; K Pahlavan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-06       Impact factor: 8.829

9.  Motor activity in depressed patients treated with carbamazepine.

Authors:  R T Joffe; T W Uhde; R M Post; M D Minichiello
Journal:  Biol Psychiatry       Date:  1987-08       Impact factor: 13.382

10.  Psychomotor retardation found in college students seeking counseling.

Authors:  T J Barkley; W W Tryon
Journal:  Behav Res Ther       Date:  1995-11
View more
  2 in total

Review 1.  Psychomotor retardation in depression: biological underpinnings, measurement, and treatment.

Authors:  Jeylan S Buyukdura; Shawn M McClintock; Paul E Croarkin
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-10-31       Impact factor: 5.067

Review 2.  Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications.

Authors:  Djamila Bennabi; Pierre Vandel; Charalambos Papaxanthis; Thierry Pozzo; Emmanuel Haffen
Journal:  Biomed Res Int       Date:  2013-10-30       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.